TG Therapeutics
TGTX
TGTX
106 hedge funds and large institutions have $345M invested in TG Therapeutics in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less capital invested
Capital invested by funds: $359M → $345M (-$13.6M)
2.68% less ownership
Funds ownership: 54.11% → 51.43% (-2.7%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
106
Holding in Top 10
–
Calls
$5.15M
Puts
$5.11M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$5.33M | |
| 3 | +$5.03M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$4.01M |
| 5 |
CCI
Columbus Circle Investors
|
+$3.94M |
Top Sellers
| 1 | -$8.15M | |
| 2 | -$4.32M | |
| 3 | -$1.87M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$1.71M |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$1.6M |